Bionano Genomics, Inc. (BNGO) Financials

BNGO Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 158.0 million 75.2 million
2023-12-31 214.4 million 118.2 million
2023-09-30 181.9 million 62.9 million
2023-06-30 271.4 million 56.6 million

BNGO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -28.2 million 3.0 million
2023-12-31 -35.0 million 3.4 million
2023-09-30 -26.4 million 4.0 million
2023-06-30 -37.2 million 3.9 million

BNGO Net Income

No data available :(

BNGO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 52.8 million - -
2023-12-31 101.9 million - 9.6 million
2023-09-30 63.6 million - 10.1 million
2023-06-30 77.1 million - 10.7 million

BNGO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 52.7 million
2023-12-31 45.8 million
2023-09-30 35.0 million
2023-06-30 31.5 million

BNGO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 26000 9.8 million - -
2023-12-31 745000 11.7 million 15.7 million -
2023-09-30 75000 13.8 million 24.9 million -
2023-06-30 511000 14.6 million 26.9 million -

BNGO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 8.8 million 5.9 million
2023-12-31 10.7 million 8.3 million
2023-09-30 9.3 million 6.6 million
2023-06-30 8.7 million 6.4 million

BNGO

Price: $1.14

52 week price:
0.71
8.20

Earnings Per Share: -6.81 USD

P/E Ratio: -0.16

Exchange: NCM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 6.9 million

Market Capitalization: 63.9 million

Links: